Comparative effectiveness of gliclazide modified release vs sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes

Emmanuelle Jacquot
Emmanuelle Jacquot
Viviana Cortese
Viviana Cortese
Melanie J Davies
Melanie J Davies

Diabetes, obesity & metabolism, 2020.

Cited by: 0|Views0
WOS

Abstract:

In this real-world study, second-line gliclazide MR was more effective than sitagliptin in reducing HbA , with similar durability and persistence and low rates of hypoglycaemic events, in individuals with type 2 diabetes on metformin treatment and HbA above the target of 7.0%. This article is protected by copyright. All rights reserved.

Code:

Data:

Get fulltext within 24h
Bibtex
Upload PDF

1.Your uploaded documents will be check within 24h, and coins will be credited to your account.

2.As the current system does not support cash withdrawal, you can add staff WeChat (AMxiaomai) to receive it as a red packet.

3.10 coins will be exchanged for 1 yuan.

?

Upload a single paper

for 5 coins

Wechat's Red Packet
?

Upload 50 articles

for 280 coins

Wechat's Red Packet
?

Upload 200 articles

for 1200 coins

Wechat's Red Packet
?

Upload 500 articles

for 3000 coins

Wechat's Red Packet
?

Upload 1000 articles

for 7000 coins

Wechat's Red Packet
Your rating :
0

 

Tags
Comments